Skip to main content

Opera Phenix OptIQ High-Content Imaging System - Single Camera

The single camera Opera Phenix OptIQ™ System is configured for the research and budget of biopharma start-ups and smaller academic labs. A blend of innovation and affordability, this single-camera imager is engineered to help you accelerate your research and discoveries.

What's new:

  • >95% QE camera(s)
  • Advanced laser-based autofocus
  • Hypoxia applications
  • 10x high NA lens
  • Phenologic.AI classification tools
  • Find Organoids building block
For research use only. Not for use in diagnostic procedures.
Add to compare Add to compare
Remove
Part #: HH25002001
Imaging Modality:
AI-based phase contrast, Brightfield, Confocal, Digital phase contrast, Fluorescence

Loading...

Automate high-content imaging with the Opera Phenix OptIQ system

Scale smarter: Automate high-content imaging with the Opera Phenix OptIQ system

Peace-of-mind

plate:: handler™ FLEX automation and imaging options provided and serviced by Revvity, with a single point of contact.

Easy-to-use

Ready-to-use application templates covering major use cases.

Free-up resources, increase utilization and safeguard results

Supports autonomous 24x7 plate processing with plates to be imaged in sequence, in loops or following user-defined schedules Full barcode tracking is included.

Shared equipment use

Users can queue plates for imaging with user-specific methods and adjustable priorities within the software.

Grows with your needs

Seamless upgrade path, with plate::handler™ FLEX sharing the same hardware & software components as our larger full-workflow automation platforms.

Hypoxia options for incubator

Combine your automated set up with a hypoxia compatible incubator to enable applications under hypoxic conditions.

Overview

Opera Phenix OptIQ high-content imager (single camera) for your high-content applications.

Key features:

  • Improved Camera
  • Microlens-enhanced spinning disk confocality
  • Automated water-immersion objectives
  • Machine learning
  • Intelligent image acquisition
  • Powerfully simple analysis
  • 3D analysis
  • Find Organoids building block

Specifications

Automation Compatible
Yes
Brand
Opera Phenix OptIQ
Imaging Modality
AI-based phase contrast
Brightfield
Confocal
Digital phase contrast
Fluorescence
Unit Size
1 unit

Citations

Resources

Are you looking for resources, click on the resource type to explore further.

1-6 of 20 Resources
Whitepaper Icon
Whitepaper
A brand-new modality on the horizon: how targeted protein degradation can address the unmet need in drug discovery and development

Targeted protein degradation (TPD) is an emerging drug discovery modality that offers the potential to probe biological pathways...

Whitepaper Icon
Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm

RNA-based therapeutics have garnered significant attention in recent years, fueled by the success of the mRNA COVID-19 vaccines...

Whitepaper Icon
Whitepaper
Artificial intelligence, machine learning and deep learning: applications in cellular imaging for improved drug discovery productivity

There has been a lot of buzz around artificial intelligence, machine learning and deep learning. Is the reality living up to the...

Whitepaper Icon
Whitepaper
Assessing juvenile batten disease on Brain Development in In Vitro 3D organoid models

Neuronal ceroid lipofuscinosis (NCL) is a complex, rare, and fatal disease belonging to a larger group of lysosomal storage...

Whitepaper Icon
Whitepaper
Cell painting - a cellular imaging and machine learning approach to drug discovery

Phenotypic Drug Discovery Re-Imagined

Cell Painting is a phenotypic screening method and a powerful application of high-content...

Whitepaper Icon
Whitepaper
COVID-19 therapeutics: demand, challenges, and the future

In a lively panel discussion, Dr. Kevin Coombs, Dr. Randal Ketchem, Dr. Mansoor Amiji, and Dr. Seyoum Ayehunie provided insights...

Loading...

Revvity AI Assistant Beta

Scroll Icon